NL
RPRX icon

NVWM LLC’s Royalty Pharma RPRX Stock Holding History

NVWM LLC’s Portfolio RPRX Stock Details RPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.97K Hold
53
– – ﹤0.01% 432
2026
Q1 		$2.53K Buy
53
+1
+2% +$44 ﹤0.01% 439
2025
Q4 		$2.03K Hold
52
– – ﹤0.01% 469
2025
Q3 		$1.84K Hold
52
– – ﹤0.01% 452
2025
Q2 		$1.87K Hold
52
– – ﹤0.01% 433
2025
Q1 		$1.6K Buy
52
+1
+2% +$32 ﹤0.01% 424
2024
Q4 		$1.31K Hold
51
– – ﹤0.01% 428
2024
Q3 		$1.44K Buy
51
+1
+2% +$28 ﹤0.01% 419
2024
Q2 		$1.33K Hold
50
– – ﹤0.01% 402
2024
Q1 		$1.52K Buy
+50
New +$1.47K ﹤0.01% 373

Other funds holding RPRX

Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Swedbank
Swedbank Stockholm, Sweden $116B AUM 46.87% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

NVWM LLC's RPRX Position: Q2 2026 in Review

NVWM LLC held its Royalty Pharma (RPRX) position steady in Q2 2026 at 53 shares worth $2.97K. The position accounts for ﹤0.01% of the portfolio, ranked #432.

NVWM LLC first reported a position in RPRX in Q1 2024 and has held it in 10 quarters since. 641 funds tracked by Wall St. Rank hold RPRX as of Q2 2026.

  • NVWM LLC held 53 shares of Royalty Pharma worth $2.97K as of Q2 2026.
  • NVWM LLC left its Royalty Pharma share count unchanged in Q2 2026.
  • Royalty Pharma made up ﹤0.01% of NVWM LLC's portfolio in Q2 2026, its #432 holding.
  • NVWM LLC first reported a position in Royalty Pharma in Q1 2024 and has held it in 10 quarters since.
  • 641 funds tracked by Wall St. Rank held Royalty Pharma as of Q2 2026.

Based on NVWM LLC's 13F filing for Q2 2026, filed 29 Jul 2026.